Subungual Melanoma — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Exclude phaeochromocytoma; biopsy only if hormonally inactive, imaging-indeterminate and histology changes care
ESE guidance restricts adrenal biopsy in a patient with extra-adrenal malignancy to lesions that are hormonally inactive, not conclusively benign on imaging, and where histology would alter management. Phaeochromocytoma must be excluded before needle biopsy because of catecholamine-crisis risk.
Reference: European Society of Endocrinology 2023 adrenal incidentaloma guideline. https://www.ese-hormones.org/publications/directory/ese-clinical-practice-guideline-on-the-management-of-adrenal-incidentalomas-in-collaboration-with-the-european-network-for-the-study-of-adrenal-tumors/